Han M, Di Natale M, Lei E, Furness J, Finkelstein D, Hao M
Acta Neuropathol Commun. 2025; 13(1):58.
PMID: 40075409
PMC: 11899089.
DOI: 10.1186/s40478-025-01956-7.
Szegvari E, Holec S, Woerman A
J Neurochem. 2025; 169(3):e70021.
PMID: 40026260
PMC: 11874209.
DOI: 10.1111/jnc.70021.
Tullo S, Park J, Gallino D, Park M, Mar K, Novikov V
Commun Biol. 2025; 8(1):288.
PMID: 39987244
PMC: 11846974.
DOI: 10.1038/s42003-025-07680-1.
Mesentier-Louro L, Goldman C, Ndayisaba A, Buonfiglioli A, Rooklin R, Schuldt B
bioRxiv. 2025; .
PMID: 39975381
PMC: 11839026.
DOI: 10.1101/2025.02.09.637107.
Theologidis V, Ferreira S, Jensen N, Gomes Moreira D, Ahlgreen O, Hansen M
Acta Neuropathol Commun. 2025; 13(1):32.
PMID: 39962601
PMC: 11834571.
DOI: 10.1186/s40478-025-01948-7.
Structures of Oligomeric States of Tau Protein, Amyloid-β, α-Synuclein and Prion Protein Implicated in Alzheimer's Disease, Parkinson's Disease and Prionopathies.
Cehlar O, Njemoga S, Horvath M, Cizmazia E, Bednarikova Z, Barrera E
Int J Mol Sci. 2024; 25(23).
PMID: 39684761
PMC: 11641156.
DOI: 10.3390/ijms252313049.
A-synuclein prion strains differentially adapt after passage in mice.
Holec S, Khedmatgozar C, Schure S, Pham T, Woerman A
PLoS Pathog. 2024; 20(12):e1012746.
PMID: 39642110
PMC: 11623799.
DOI: 10.1371/journal.ppat.1012746.
In Vitro Cell Model Investigation of Alpha-Synuclein Aggregate Morphology Using Spectroscopic Imaging.
Swaminathan P, Klingstedt T, Theologidis V, Gram H, Larsson J, Hagen L
Int J Mol Sci. 2024; 25(22).
PMID: 39596523
PMC: 11594916.
DOI: 10.3390/ijms252212458.
Mitochondrial Dysfunction in Parkinson's Disease: A Contribution to Cognitive Impairment?.
Scorziello A, Sirabella R, Sisalli M, Tufano M, Giaccio L, DApolito E
Int J Mol Sci. 2024; 25(21).
PMID: 39519043
PMC: 11546611.
DOI: 10.3390/ijms252111490.
Human midbrain organoids: a powerful tool for advanced Parkinson's disease modeling and therapy exploration.
Cui X, Li X, Zheng H, Su Y, Zhang S, Li M
NPJ Parkinsons Dis. 2024; 10(1):189.
PMID: 39428415
PMC: 11491477.
DOI: 10.1038/s41531-024-00799-8.
Spiral volumetric optoacoustic tomography of reduced oxygen saturation in the spinal cord of M83 mouse model of Parkinson's disease.
Combes B, Kalva S, Benveniste P, Tournant A, Law M, Newton J
Eur J Nucl Med Mol Imaging. 2024; 52(2):427-443.
PMID: 39382580
PMC: 11732882.
DOI: 10.1007/s00259-024-06938-w.
Selection of DNA aptamers that prevent the fibrillization of α-synuclein protein in cellular and mouse models.
McConnell E, Chan D, Ventura K, Callahan J, Harris K, Hunt V
Mol Ther Nucleic Acids. 2024; 35(3):102251.
PMID: 39377064
PMC: 11456556.
DOI: 10.1016/j.omtn.2024.102251.
Olfactory deficit and gastrointestinal dysfunction precede motor abnormalities in alpha-Synuclein G51D knock-in mice.
Kim Y, McInnes J, Kim J, Liang Y, Veeraragavan S, Garza A
Proc Natl Acad Sci U S A. 2024; 121(39):e2406479121.
PMID: 39284050
PMC: 11441490.
DOI: 10.1073/pnas.2406479121.
α-Synuclein strain propagation is independent of cellular prion protein expression in a transgenic synucleinopathy mouse model.
So R, Amano G, Stuart E, Ebrahim Amini A, Aguzzi A, Collingridge G
PLoS Pathog. 2024; 20(9):e1012517.
PMID: 39264912
PMC: 11392418.
DOI: 10.1371/journal.ppat.1012517.
Involvement of K3.4 Channel in Parkinson's Disease: A Key Player in the Control of Midbrain and Striatum Differential Vulnerability during Disease Progression?.
Magliocca G, Esposito E, Tufano M, Piccialli I, Rubino V, Tedeschi V
Antioxidants (Basel). 2024; 13(8).
PMID: 39199246
PMC: 11351402.
DOI: 10.3390/antiox13080999.
A dual target molecular magnetic resonance imaging probe for noninvasive profiling of pathologic alpha-synuclein and microgliosis in a mouse model of Parkinson's disease.
Sun X, Badachhape A, Bhandari P, Chin J, Annapragada A, Tanifum E
Front Neurosci. 2024; 18:1428736.
PMID: 39114484
PMC: 11303179.
DOI: 10.3389/fnins.2024.1428736.
Cognitive dysfunction in animal models of human lewy-body dementia.
Haikal C, Winston G, Kaplitt M
Front Aging Neurosci. 2024; 16:1369733.
PMID: 39104707
PMC: 11298446.
DOI: 10.3389/fnagi.2024.1369733.
Molecular properties and diagnostic potential of monoclonal antibodies targeting cytotoxic α-synuclein oligomers.
Nielsen J, Lauritsen J, Pedersen J, Nowak J, Bendtsen M, Kleijwegt G
NPJ Parkinsons Dis. 2024; 10(1):139.
PMID: 39075088
PMC: 11286781.
DOI: 10.1038/s41531-024-00747-6.
Mutant mice with rod-specific VPS35 deletion exhibit retinal α-synuclein pathology-associated degeneration.
Fu C, Yang N, Chuang J, Nakajima N, Iraha S, Roy N
Nat Commun. 2024; 15(1):5970.
PMID: 39043666
PMC: 11266608.
DOI: 10.1038/s41467-024-50189-0.
Rational design of structure-based vaccines targeting misfolded alpha-synuclein conformers of Parkinson's disease and related disorders.
Flores-Fernandez J, Pesch V, Sriraman A, Chimal-Juarez E, Amidian S, Wang X
Bioeng Transl Med. 2024; 9(4):e10665.
PMID: 39036077
PMC: 11256163.
DOI: 10.1002/btm2.10665.